# Addex Therapeutics Ltd.: Form 20-F for the period ended Dec 31, 2023

- Company: [Addex Therapeutics Ltd.](/companies/adxn.md) (CIK 1574232)
- Form: 20-F
- Filed: 2024-04-18
- Accepted by EDGAR: Apr 18, 2024, 06:15 ET
- Period: 2023-12-31
- Accession: 0001104659-24-048532
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1574232/000110465924048532/adxn-20231231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1574232/000110465924048532/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2023-01-01 to 2023-12-31 | CHF 1.6m | ifrs-full:RevenueFromContractsWithCustomers |
| Operating income | 12 months, 2023-01-01 to 2023-12-31 | −CHF 10.3m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2023-01-01 to 2023-12-31 | CHF 0 | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2023-01-01 to 2023-12-31 | −CHF 10.6m | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months, 2023-01-01 to 2023-12-31 | −CHF 0.14 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2023-01-01 to 2023-12-31 | −CHF 0.14 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2023-01-01 to 2023-12-31 | −CHF 8.0m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2023-01-01 to 2023-12-31 | CHF 6.8k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2023-12-31 | CHF 3.9m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2023-12-31 | CHF 4.2m | ifrs-full:CurrentAssets |
| Total assets | at 2023-12-31 | CHF 4.6m | ifrs-full:Assets |
| Current liabilities | at 2023-12-31 | CHF 2.9m | ifrs-full:CurrentLiabilities |
| Shareholders' equity | at 2023-12-31 | CHF 1.1m | ifrs-full:Equity |
| Shares outstanding | at 2023-12-31 | 125,195,393 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1574232/000110465924048532/adxn-20231231x20f.htm

Filed Apr 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-048532. Last ingested by Listed: Oct 29, 2026, 06:06 ET. No prices; not investment advice.